Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis
21 Sep 2020
byRoshini Claire Anthony
Daily albumin infusion to achieve serum albumin levels of ≥30 g/L did not reduce the risk of infection, renal dysfunction, or mortality in individuals with acute decompensated cirrhosis, according to results of the ATTIRE* study presented at ILC 2020.
Daily albumin infusion fails to reduce infection, renal dysfunction in decompensated cirrhosis
21 Sep 2020
